61617-29-6

Usage

Uses

Used in Pharmaceutical Industry:
Oleanolic acid-3-O-beta-D-xylopyranoside is used as a therapeutic agent for its potential applications in treating various health conditions, such as cancer, liver diseases, and inflammation-related disorders. Its anti-inflammatory, antioxidant, anti-tumor, and hepatoprotective properties make it a valuable compound for the development of new pharmaceutical drugs.
Used in Natural Health Products:
Oleanolic acid-3-O-beta-D-xylopyranoside is used as an active ingredient in natural health products due to its potential health benefits. Its presence in various plant sources allows for its incorporation into dietary supplements, herbal remedies, and other natural health products to support overall health and well-being.
Further research is ongoing to explore the full therapeutic potential of Oleanolic acid-3-O-beta-D-xylopyranoside and possible side effects, ensuring its safe and effective use in various applications.

Upstream product

• 75799-17-6 oleanolic acid 3-O-β-D-xylopyranosyl-(1-3)-α-L-rhamnopyranosyl-(1-2)-α-L-arabinopyranoside 
• 76742-94-4 oleanolic acid 3-O-β-D-glucopyranosyl-(1-4)-β-D-glucopyranosyl-(1-4)-β-D-xylopyranosyl-(1-3)-α-L-rhamnopyranosyl-(1-2)-α-L-arabinopyranoside 
• 75799-17-6 oleanolic acid 3-O-β-D-ribopyranosyl-(1-3)-α-L-rhamnopyranosyl-(1-2)-α-L-arabinopyranoside 
• 75799-17-6 oleanolic acid 3-O-β-D-xylopyranosyl-(1-3)-α-L-rhamnopyranosyl-(1-2)-α-L-arabinopyranoside 
• 76742-94-4 oleanolic acid 3-O-β-D-glucopyranosyl-(1->4)-β-D-glucopyranosyl-(1->4)-β-D-ribopyranosyl-(1->3)-α-L-rhamnopyranosyl-(1->2)-α-L-arabinopyranoside 
• 101020-99-9 oleanolic acid 28-O-β-D-glucopyranoside 3-O-2)-O-β-D-glucopyranosyl-(1->3)-α-L-arabinopyranoside> 
• 75799-18-7 oleanolic acid 3-O-3)-O-α-L-rhamnopyranosyl-(1->2)>-α-L-arabinopyranoside 
• 72629-77-7 C₅₂H₈₄O₂₀ 
• 72629-77-7 oleanolic acid 3-O-β-D-glucopyranosyl-(1-4)-β-D-xylopyranosyl-(1-3)-α-L-rhamnopyranosyl-(1-2)-α-L-arabinopyranoside 

Downstream Products

• 508-02-1 Oleanolic acid 
• 5328-37-0 L-arabinose 

Relevant academic research and scientific papers

New cytotoxic oleanane saponins from the infructescences of Polyscias amplifolia from the Madagascar rainforest

Bioassay-guided fractionation of an ethanolic extract of the infructescences of Polyscias amplifolia resulted in the isolation of two new oleanolic acid saponins, polyfoliolides A (1) and B (2), in addition to the two known saponins 3-O-β-D-galactopyrano-syloleanolic acid (3) and 3-O-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyloleanolic acid (4). The structures of the two new compounds were established as 3-O-β-D-galactopyranosyl-(1→4)-β-D-xylopyranosyloleanolic acid (1) and 3-O-β-D-galactopyranosyl-(1→4)-α-L-arabinopyranosyloleanolic acid (2) on the basis of extensive 1D and 2D NMR spectroscopic data interpretation and chemical conversions. All the isolated compounds showed weak cytotoxicity against A2780 human ovarian cancer cell line, with IC50 values in the range 6.7 to 10.8 μg/mL.

TRITERPENE SAPONINS FROM Thalictrum minus. STRUCTURE OF THALICOSIDE B

The epigeal part of Thalictrum minus L. has yielded a new bidesmoside - thalicoside B - which has the structure of oleanolic acid 28-O-β-D-glucopyranoside 3-O- 2)-O-β-D-glucopyranosyl-(1 -> 3)-α-L-arabinopyranoside>.

TRITERPENE GLYCOSIDES AND THEIR GENINS FROM Thalictrum foetidum. I. THE STRUCTURE OF FOETOSIDE C

A new glycoside - foetoside C - has been isolated from the epigeal part of Thalictrum foetidum L. and, on the basis of chemical transformations and spectral characteristics its structure has been established as oleanolic acid 28-6)-O-β-D-glucopyranoside> 3-O-3)-O-α-L-rhamnopyranosyl-(1->2)-α-L-arabinopyranoside>.